Mice and Mice maintenance WT (C57BL/6J) and Ldlr−...
創建於:2025年12月25日
使用 GPT-5.2 Pro 回答 Chat01
創建於:2025年12月25日
使用 GPT-5.2 Pro 回答 Chat01
Mice and Mice maintenance
WT (C57BL/6J) and Ldlr−/− (B6.129S7-Ldlrtm1Her) 6-8 week old female mice were purchased from Jackson Laboratory. Jak2VF MxCre mice were created and reported previously.12 Bone Marrow (BM) from poly I:C treated female WT (C57BL/6J) or Jak2VF MxCre mice were transplanted into irradiated (10.5 Gy for 8.4 minutes) WT or Ldlr−/− recipients. WT BM recipients were fed a chow diet, while Ldlr−/− recipients were fed a Western diet (WD) (Harlan Teklad, TD88137) for the indicated period of time. Mice were housed under a 12 hr light /dark cycle with ad libitum access to water and food. All protocols were approved by the Institution Animal Care and Use Committee of Columbia University.
Atherosclerosis Lesion Analysis and Metabolic profiling
The heart with the aortic root attached was embedded in paraffin and then serially sectioned. The sections were stained with hematoxylin and eosin or trichrome (sigma, HT15) for morphometric lesion analysis. Five sections per mouse was used for total lesional and necrotic core area quatification as previously described.13 All these in vivo studies including the ones described below such as immunofluorescence and immunohistochemistry staining were performed with a blinding protocol. Each animal was assigned an arbitrary number and the data was collected based on the assigned number while the genotype of the mouse and experimental conditions were unknown to the data collector. Total plasma cholesterol and HDLcholesterol were measured using kits from WAKO diagnostics, total plasma triglyceride was measured using kit from Thermo (TR22421).
Immunofluorescence Staining
Paraffin-embedded slides were deparaffinized with Histo-clear and then rehydrated in deceasing concentration of ethanol. Identification of macrophages, neutrophils in atherosclerotic lesions were performed by immunostaining using anti-mouse CD107b (Mac-3) (BD 553322, 1˖100), anti-mouse Ly6G (Biolegend 127601, 1:200), anti-myeloperoxidase (R&D BAF3667, 1:30) Lesional MerTK was incubated with biotin-labeled MerTK (R&D system, BAF591) and Mac-3. The sections were incubated with primary antibodies overnight at 4˚C overnight then incubated with secondary antibodies for 30 min. For antibody specificity in immunofluorescence staining, isotype matched normal IgG was used as the control for each assay. Iron staining and TUNEL staining were performed using a commercially available kit (Abcam ab83366) and (Roche 12156792910). Images were acquired by using Leica immunofluorescence microscope.
Immunohistochemistry
Paraformaldehyde-fixed and paraffin-embedded lesions were deparaffinized and rehydrated, then incubated with anti-Mac-3 antibody (BD 553322, 1˖100) or with anti-Ter119 antibody (eBioscience 14-5921-82, 2 1:200) at 4˚C overnight and with secondary anti-Rat IgG (VECTOR, MP-7405) for 30 min. The reaction was developed with diaminobenzidine (DAB) staining (VECTOR, SK-4100). For antibody specificity, isotype matched normal IgG was used as the control for each assay.
Flow Cytometry
Flow cytometry to quantify peripheral blood neutrophils, monocytes, platelet-neutrophil aggregates, platelet-monocyte aggregates or bone marrow hematopoietic stem and progenitor cells profiles were performed as previously described.13 For analysis of erythrocytes from mice and human samples, the red blood cells were labeled with antibody against Ter119 (eBioscience 14-5921-82) or CD47 (BD 556045 for human and BD 563585 for mice) or Calreticulin (Abcam ab22683) in staining buffer (30 min, 4°C). For neutrophils activity assays, neutrophils were stained with antibodies against to CD45 (Biolegend 103133),
CD11b (Biolegend 101211), Ly6G (BD 561104) in staining buffer (20 min, 4°C). Formyl-Nle-Leu-PheNle-Tyr-Lys (FMLP) conjugated with Fluorescein (Thermofisher, 10 min, 4°C) was used to detect FPR1 expression. Flow cytometry was performed using the LSR Fortessa or LSRII (Beckton Dickinson) and data were analyzed using FlowJo software (Beckton Dickinson). Isotype matched normal IgG was used as the control in each flow cytometry assay.
Intravital Microscopy
Leukocyte-endothelial interactions along the carotid artery were analyzed by intravital epifluorescence microscopy. Mice were placed in supine position, and the right jugular vein was cannulated with a catheter for antibody injection. Intravital microscopy was performed after injection of antibodies to Ly6G (1μg; clone 1A8; eBioscience), Ly6C (1μg, HK1.4, Biolegend), and CD11b (1μg, M1/70, eBioscience) using an Olympus BX51 microscope equipped with a Hamamatsu 9100-02 EMCCD camera, and a 10× salineimmersion objective. Movies of 30s were acquired and analyzed offline. Rolling flux was assessed as cell moving across a line perpendicular to the carotid artery. Cells were considered adherent if not moving
during 30 seconds.
Flow Adhesion Assays
Flow adhesion assays were performed in vitro using IBIDI-Slide IV 0.1 flow chambers (Ibidi). Flow chambers were coated with 12 μg/mL of intercellular adhesion molecule-1 (ICAM1), vascular cell adhesion molecule-1 (VCAM1) and P-selectin (all from R&D systems). Neutrophils were stained with Ly6G (eBioscience 17-9668-82ˈ1:100) for 15 min on ice. After adding 1mM of Ca2+/Mg2+, 5x105 neutrophils were placed into flow chambers and flow was created during 3 minutes at 5μL/min at 37°C using a highprecision syringe pump. After perfusion with PFA 4%, cells were washed with PBS. Pictures were acquired using a climate chamber fluorescence microscope (Leica, DMi8) and adhered neutrophils were quantified using ImageJ software.
雷帕霉素/恩那度司他 atherosclerosis study
Chimeric Ldlr−/− mice with 20% Mx1-Jak2VF and 80% GFP bone marrow were administered WTD ENVIGO (TD.88137) supplemented with ruxolitinib (2 g/kg)35,36 for 12 weeks.
Bulk cell RNA-seq (做斑块/外周血的代谢、脂质组学等分析)
CD11b+ splenocytes were isolated from wild-type recipient mice 11 weeks after BMT. For hypercholesteraemia experiments, BMT was conducted in Ldlr−/− mice, four weeks after which a WTD was administered and sustained for seven weeks. Following WTD, mice were killed and CD11b+ splenocytes were collected and isolated into TRIzol reagent (Thermo Fisher Scientific). Aortic roots were also removed. RNA was isolated with RNeasy kits (Qiagen) and RNA-seq experiments were conducted as previously described37 on a NexSeq 500 (illumina). Genes were considered differentially expressed if they were significant at 5% false discovery rate (FDR) by DESeq2 and were at least twofold different in average reads per kilobase of transcript per million mapped reads (RPKM). Gene ontology analysis was conducted using the PANTHER database38. Extended Data Fig. 1 displays RNA-seq data. All data have been deposited into a public repository.
Aortic single-cell digest
Following termination of WTD, aortas were isolated, digested with 2.5 mg/ml liberase (Millipore Sigma, LIBTM-RO), 120 U/ml hyaluronidase (Millipore Sigma, H3506), and 160 U/ml DNase I (Millipore Sigma, DN25) for 45 min at 37 °C as previously described31. For qPCR analysis, cells were washed and stained with CD11b-APC, BV786-Ly6G, CD45.1-PE and CD45.2-BV421. Cells were sorted on a BD Influx sorter and isolated directly into TRIzol. qPCR analysis was conducted as described above.
Single-cell RNA-seq
For single-cell RNA-seq (scRNA-seq), after 12 weeks WTD, Ldlr−/− mice with control, Mx1-Jak2VF, or Mx1-Jak2VFGsdmd−/− bone marrow (not in a chimeric model) were killed, and aortas were digested as indicated above, except that necrosulfonamide (20 μM, Torcis) was supplemented in all media to prevent ex vivo necroptosis and gasdermin D oligomerization. Cell digests were sorted by flow cytometry for DAPI−CD45+ events, then run on Genomics scRNA-seq.
Western blot analysis(改为动脉粥样硬化斑块)
Lung tissue homogenate and macrophages were harvested, and proteins were extracted using RIPA buffer (Beyotime) containing protease inhibitors cocktail (Roche, Mannheim, Germany). To concentrate supernatants for western blot, 700 μL 100% methanol and 175 μL trichloromethane were added to 700 μL supernatant and vortexed for 30 s. Supernatants were then centrifuged at 13000 rpm for 5 min at 4°C. The supernatant liquid was removed, and added 700 μL 100% methanol, then centrifuged at 13000 rpm for 5 min at 4°C. Supernatants were discarded. And the remaining pellet was resuspended in 20 μL10% SDS, then added 4 μL 5×SDS -PAGE sample loading buffer (Beyotime) and boiled for 10 min at 95°C. The protein concentrations were measured with PierceTM Rapid Gold BCA Protein Assay Kit (Thermo Fisher Scientific, Grand Island, USA). Equal amounts of protein or all protein from supernatants were subjected to 8%-12% gradient polyacrylic amide gel under reducing conditions. Gels were transferred into polyvinylidene difluoride membranes (Millipore, USA), blocked with 5% fat-free milk or 5% albumin from bovine serum (BSA, Biofroxx, Germany) at room temperature for 1.5 h. The blots were reacted with the primary antibody at 4 °C overnight, followed by horseradish peroxidaseconjugated secondary antibody (1:1000; Cell Signaling Technology, USA), and detection by ChemiDoc XRS (Bio-Rad, USA). The intensities of the bands were quantified using the Image Lab Analyzer software (Bio-Rad). β-actin, α-tubulin, or GAPDH were used as a loading control. The antibodies used in the study are shown in Table 1.
Real-time PCR (用动脉粥样硬化小鼠模型)
Total RNA was isolated from macrophages and lungs using RNAiso (TaKaRa Clontech, Japan). Reverse transcription with approximately 1 μg of total RNA was carried out in a T100TM Thermal Cycler (Bio-Rad, USA) using PrimeScriptTM RT reagent Kit (TaKaRa Clontech). Targeted gene expressions were measured by quantitative real-time PCR analyses using SYBR® Premix Ex TaqTM II system (TaKaRa Clontech) on a Bio-Rad real-time PCR system (CFX96 TouchTM; Bio-Rad, USA). The qPCR program was initiated at 95 °C for 30 s; 40 cycles of 95 °C for 15 s, and 60 °C for 30 s. β-actin was used as an endogenous reference gene. The primers in Table 2 were purchased from Sangon Biotech (Shanghai, China). Gene expression abundance was calculated by the 2−ΔΔCt method.
Cytokine detection
IL-1β contents in the cell culture supernatant were measured after an additional 24 h of incubation using appropriate ELISA kits (Cat# TNF-α: 88-7324; IL-1β: 88-7013; Invitrogen, Thermo Fisher Scientific, USA).
我在做题为【Jak2V617f突变激活中性粒细胞mTOR–HIF-1α 通路,驱动脂质代谢重编程在动脉粥样硬化中的机制及干预研究】的研究,上述是我在文献中找到的实验方法描述(参数或细胞、通路等可能不一致),请根据主要内容及研究思路,写一份中文的研究方法,要求尽量详细,修正存在的错误,参考顶刊或国自然标书的实验设计方法,以及表达方式,保证逻辑的清晰,表达科学
下面给出一份围绕“Jak2V617F突变激活中性粒细胞 mTOR–HIF‑1α 通路,驱动脂质代谢重编程并促进动脉粥样硬化”的中文研究方法(按顶刊/国自然标书常用写法组织)。内容在你提供文献方法基础上做了逻辑重排与关键错误修正(如 Jak2VF/MxCre 命名、WTD+药物段落不一致、10x scRNA‑seq表述、Tocris拼写等),并补充了与本课题“机制+干预+多组学验证”匹配的技术细节与质量控制(随机/盲法/排除标准等)。
JAK2V617F 突变导致中性粒细胞(neutrophil)内 mTOR 信号异常激活,继而促进 HIF‑1α 稳定与转录活化,驱动中性粒细胞发生脂质代谢重编程(脂肪酸摄取、胆固醇酯化/脂滴形成、脂氧化或合成途径再平衡),增强其黏附/浸润/效应功能,最终加重动脉粥样硬化斑块炎症与坏死核心形成。药物或遗传学阻断 mTOR–HIF‑1α 轴可减轻斑块负担并纠正代谢异常。
你提供文本“10.5 Gy for 8.4 minutes”属于设备相关曝光时间,不利于可重复性;顶刊/标书写法建议统一按**总剂量(Gy)**并注明是否分次照射。以下为规范写法。
为验证“mTOR→HIF‑1α→代谢重编程→粥样硬化”的因果链,建议至少设置:
你提供文本中“雷帕霉素/恩那度司他 atherosclerosis study”但正文却写“ruxolitinib(2 g/kg)”,这是段落标题与内容不一致的错误。正确做法是:
- 若该段确实做 JAK 抑制,应将标题改为“ruxolitinib 干预”;
- 若该段要写雷帕霉素/恩那度司他,应把药物及剂量、给药途径写成对应的 rapamycin/enarodustat,并把 ruxolitinib 作为独立对照段落。
(这里不强行给“唯一固定剂量”,避免与实际药代/平台不符;顶刊论文通常也会在补充材料写清楚最终采用剂量。)
为兼顾“形态学+成分+坏死核心+脂质沉积”,建议主动脉根部切片为主,辅以全主动脉铺片(en face)。
你提供的方法包含黏附、活体滚动/黏附等,非常契合“中性粒细胞促粥样硬化”的机制链。建议在本课题中把功能实验与 mTOR–HIF‑1α/代谢读出联动分析。
你提供文本“run on Genomics scRNA‑seq”表述不规范,建议改为10x Genomics Chromium。
“Torcis”应为 Tocris。
你在括号中提出“做斑块/外周血的代谢、脂质组学等分析”,这是本课题的关键亮点,建议写成“样本‑平台‑质控‑统计”的完整链条。
你提供文本 WB/qPCR 以“肺组织与巨噬细胞”为主,与你课题的“动脉粥样硬化斑块/中性粒细胞”不匹配,应修正为以下样本来源。
你提供文本中“trichloromethane”建议在中文写作中统一写为氯仿(chloroform),方法可保留“甲醇‑氯仿沉淀浓缩上清蛋白”用于分泌蛋白/上清分析。
本研究以骨髓移植构建 Jak2^V617F 造血嵌合的 Ldlr^-/- 动脉粥样硬化模型(含 20%嵌合模拟 CHIP),通过西方型饮食诱导斑块形成。采用组织学定量(主动脉根部 H&E/Masson、必要时 en face)评价斑块面积、坏死核心与胶原含量;采用免疫荧光/免疫组化与流式细胞术解析斑块中性粒细胞浸润、mTOR–HIF‑1α 通路活化(p‑S6、HIF‑1α)及脂质代谢表型(脂滴/脂肪酸摄取等);结合活体显微镜与体外流动黏附实验评估中性粒细胞‑内皮相互作用。进一步对分选中性粒细胞及斑块免疫细胞开展 bulk RNA‑seq、10x scRNA‑seq、代谢组与脂质组学,系统刻画 Jak2^V617F 驱动的代谢重编程网络。最后以雷帕霉素(mTOR 抑制)及 HIF 通路调控(如恩那度司他救援验证或HIF‑1α抑制阻断验证)进行干预,明确 mTOR–HIF‑1α 轴在 Jak2^V617F 相关动脉粥样硬化中的因果作用与潜在治疗靶点。
如果你希望我把这份“研究方法”进一步升级成国自然标书格式(按“研究内容1/2/3:目的‑方案‑关键技术‑预期结果‑风险与替代方案”逐条展开),我也可以在不额外问你问题的情况下,直接基于你这个题目给出一版更像标书的结构化文本;同时也可以把**“雷帕霉素/恩那度司他/ruxolitinib”**三者在你课题中的逻辑定位写得更“因果链闭环”(抑制‑救援‑对照)。